ArticleBMJ open2017

Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs.

Viviana Giannuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.